| dc.contributor.author | Coban, A. Y. | |
| dc.contributor.author | Tanyel, E. | |
| dc.contributor.author | Fisgin, N. Tasidelen | |
| dc.contributor.author | Darka, O. | |
| dc.contributor.author | Tulek, N. | |
| dc.contributor.author | Durupinar, B. | |
| dc.date.accessioned | 2020-06-21T15:18:46Z | |
| dc.date.available | 2020-06-21T15:18:46Z | |
| dc.date.issued | 2007 | |
| dc.identifier.issn | 1120-009X | |
| dc.identifier.issn | 1973-9478 | |
| dc.identifier.uri | https://doi.org/10.1179/joc.2007.19.5.596 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/19754 | |
| dc.description | WOS: 000251034900018 | en_US |
| dc.description | PubMed: 18073161 | en_US |
| dc.description.abstract | … | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Taylor & Francis Ltd | en_US |
| dc.relation.isversionof | 10.1179/joc.2007.19.5.596 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Mutant prevention concentrations of tetracycline, rifampicin and ciprofloxacin for Brucellae melitensis | en_US |
| dc.type | letter | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 19 | en_US |
| dc.identifier.issue | 5 | en_US |
| dc.identifier.startpage | 596 | en_US |
| dc.identifier.endpage | 598 | en_US |
| dc.relation.journal | Journal of Chemotherapy | en_US |
| dc.relation.publicationcategory | Diğer | en_US |
